Qatar Investment Authority 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-18 5:20 pm Purchase | 2024-11-25 | 13G | BioXcel Therapeutics, Inc. BTAI | Qatar Investment Authority | 2,724,075 5.200% | 2,724,075 (New Position) | Filing |